DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Switzerland
  • /
  • Materials
Author Program NEWCreate Narrative
CPHN logo

CPH Group AG Stock Price

SWX:CPHN Community·CHF 357.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CPHN Share Price Performance

CHF 0
-73.20 (-100.00%)
​
CHF 0
-73.20 (-100.00%)
​
Price CHF 0
Wed, 16 Sep 26
Share Pricen/a

CPHN Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet, good value and pays a dividend.

2 Risks
2 Rewards
View Full Analysis

CPH Group AG Key Details

CHF 334.2m

Revenue

CHF 172.4m

Cost of Revenue

CHF 161.8m

Gross Profit

CHF 141.3m

Other Expenses

CHF 20.5m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
3.42
48.41%
6.13%
27.8%
View Full Analysis

About CPHN

Founded
1818
Employees
1249
CEO
Alois Waldburg-Zeil
WebsiteView website
cph.ch

CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging. The Zeochem segment produces molecular sieves for industrial and medical applications, chromatography gels for the pharmaceutical industry, and deuterated products used in analytics, pharmaceuticals, and OLED displays. This segment also operates production facilities in Switzerland, Bosnia and Herzegovina, the USA, Canada, China, and India. The Perlen Packaging segment focuses on the pharmaceutical industry, supplying coated plastic films used primarily in blister packaging to protect medications, as well as vials and containers for medical use; and PVC mono films and coated PVdC barrier films for use in the pharmaceutical industry. CPH Group AG was founded in 1818 and is based in Perlen, Switzerland.

Recent CPHN News & Updates

Analysis Article • Jul 24

CPH Group AG (VTX:CPHN) Half-Yearly Results: Here's What Analysts Are Forecasting For This Year

It's been a good week for CPH Group AG ( VTX:CPHN ) shareholders, because the company has just released its latest...

Recent updates

No updates

CPH Group AG Competitors

VETN logo

Vetropack Holding

Symbol: SWX:VETN
Market cap: CHF 411.3m
GURN logo

Gurit Holding

Symbol: SWX:GURN
Market cap: CHF 254.1m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide